New Key Statistics Module, Z-Score and F-Score
NAS:HRMY Key Ratios
Market Cap $ M | 1,950.47 |
Enterprise Value $ M | 1,752.50 |
P/E(ttm) | 16.21 |
PE Ratio without NRI | 14.31 |
Forward PE Ratio | 10.21 |
Price/Book | 3.27 |
Price/Sales | 2.96 |
Price/Free Cash Flow | 9.20 |
Price/Owner Earnings | 42.82 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 681.00 |
EPS (TTM) $ | 2.11 |
Beneish M-Score | -2.7 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 0.60 |
EV-to-EBIT | 9.06 |
EV-to-EBITDA | 8.05 |
PEG | -- |
Shares Outstanding M | 57.03 |
Net Margin (%) | 17.98 |
Operating Margin % | 25.71 |
Pre-tax Margin (%) | 25.71 |
Quick Ratio | 3.20 |
Current Ratio | 3.24 |
ROA % (ttm) | 14.52 |
ROE % (ttm) | 23.59 |
ROIC % (ttm) | 29.92 |
Dividend Yield % | -- |
Altman Z-Score | 5.40 |
HRMY Number of Guru Trades
HRMY Volume of Guru Trades
Gurus Latest Trades with NAS:HRMY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:HRMY is held by these investors
Total 2
Harmony Biosciences Holdings Inc Insider Transactions
No Available Data
News about NAS:HRMY
Total 0- 1